Other
Recombinant Zoster Vaccine
0
Pipeline Programs↗
6
Active Trials↗
4
Companies Involved↗
Recombinant Zoster Vaccine is an early-stage landscape with 0 programs across 4 companies. The most active players are Guangzhou Patronus Biotech Co., Ltd., MAXVAX Biotechnology Limited Liability Company, Jiangsu Rec-Biotechnology Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Active, not recruiting5 · 56%
Completed2 · 22%
Unknown status1 · 11%
Recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
Active, not recruiting·MMAXVAX Biotechnology Limited Liability Company·Phase 3·NCT06447779·25,000 enrolled
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
Active, not recruiting·MMAXVAX Biotechnology Limited Liability Company·Phase 3·NCT07293065·12,000 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)